Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
monoclonal antibody
Biotech
Zenas bags $200M series C to reach a handful of key mAB readouts
Zenas' $200 million series C is the company's second consecutive nine-digit financing.
Max Bayer
May 7, 2024 7:00am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
Gilead gives up on $4.9B antibody magrolimab
Apr 26, 2024 10:04am
J&J targets rare maternal-fetal disease: 'We're going for this'
Apr 2, 2024 11:23am
Pfizer axes phase 3 sickle cell study, cites recruitment issues
Mar 26, 2024 5:31pm
With new data in hand, Astria makes ph. 3 wish on shooting star
Mar 25, 2024 10:46am